logo
Select company
Select metric
$ -1.66MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
41
Sector
47
Industry
47
History
38
$ 0.53Close
$ 0.24 - $ 2.44 52-Week Range
Ticker Information

Ticker

PRPH

Company Name

PROPHASE LABS INC

Sector

Healthcare

Industry

Diagnostics & Research

Exchange

NASDAQ

PROPHASE LABS INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PRPH - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ -1.66M
3/31/2025$ -1.11M
12/31/2024$ -931K
9/30/2024$ 392K
6/30/2024$ -1.46M
3/31/2024$ -7.88M
12/31/2023$ -6.96M
9/30/2023$ -22.1M
6/30/2023$ -20.14M
3/31/2023$ -16.19M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PROPHASE LABS INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ 9.89M.
  • Over the past 5 years, PROPHASE LABS INC's average CF - Chg. Cash has been $ -49.35K.
  • The median CF - Chg. Cash for PROPHASE LABS INC during this period was $ -1.02M
  • PROPHASE LABS INC reached its highest CF - Chg. Cash over the past 5 years at $ 32.03M.
  • The lowest CF - Chg. Cash recorded by PROPHASE LABS INC in the same timeframe $ -22.1M

PROPHASE LABS INC's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
BNBX : APPLIED DNA SCIENCES INC $ -5.7MINBS : INTELLIGENT BIO SOLUTIONS INC $ -5.28MTNON : TENON MEDICAL INC $ 5.88MTRAW : TRAWS PHARMA INC $ -3.81MTXMD : THERAPEUTICSMD INC $ 837KLGVN : LONGEVERON INC $ -2.04MBOLT : BOLT BIOTHERAPEUTICS INC $ 3.4MLPCN : LIPOCINE INC $ 490.61KCYCN : CYCLERION THERAPEUTICS INC $ -1.58MXAIR : BEYOND AIR INC $ 749K

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

PRPH - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -22.1M

Minimum

Sep 30, 2023

$ 32.03M

Maximum

Mar 31, 2021

$ -49.35K

Average

$ -1.02M

Median

CF - Chg. Cash Benchmark Analysis

The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.12M with a standard deviation of $ 45.01M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -137M
max$ 137.58M
average$ 1.12M
median$ 104K
std$ 45.01M